Interleukin Genetics Announces Conference Call to Discuss Fourth Quarter and Year-End 2015 Financial Results
15 mars 2016 08h52 HE
|
Interleukin Genetics, Inc.
WALTHAM, Mass., March 15, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it will host a conference call and webcast on Thursday, March 17, 2016, at 8:30 a.m....
Interleukin Genetics and Metagenics Enter Into Agreement to Incorporate PerioPredict® Into Metagenics’ Employee Benefit Plan
18 févr. 2016 08h00 HE
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Feb. 18, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic...
Interleukin Genetics Reports Third Quarter 2015 Financial Results
12 nov. 2015 17h25 HE
|
Interleukin Genetics, Inc.
WALTHAM, Mass., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) today announced financial and operational results for its fiscal third quarter of 2015, ended September 30,...
Interleukin Genetics Collaborators Present Scientific Research Supporting Weight Management Genetic Test at the 2015 Experimental Biology Annual Meeting
01 avr. 2015 11h50 HE
|
Interleukin Genetics, Inc.
WALTHAM, Mass., April 1, 2015 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) today announced two late-breaking poster presentations supporting its Inherent Health® Weight Management...